STOCK TITAN

Autoliv (ALV) CTO Fabien Dumont receives dividend-equivalent RSU credits

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Autoliv Inc. executive Fabien Dumont, EVP & Chief Technology Officer, reported automatic increases in his restricted stock unit holdings on December 10, 2025. The filing shows small amounts of dividend-equivalent RSUs credited at no cost across several existing awards, including performance-based restricted stock units from 2023 and 2024 and time-based RSUs maturing in 2026, 2027, and 2028.

Each RSU represents a contingent right to receive one share of Autoliv common stock. The dividend equivalents accrue as additional RSUs whenever cash dividends are paid during the award period, and they follow the same vesting schedule as the underlying grants. The performance-based RSUs will vest in a single installment after the completion of their respective three-year performance periods and the compensation committee’s certification of results.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dumont Fabien

(Last) (First) (Middle)
C/O AUTOLIV, INC.
KLARABERGSVIADUKTEN 70, SECTION D5

(Street)
STOCKHOLM V7 SE-111 64

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AUTOLIV INC [ ALV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Technology Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance-Based Restricted Stock Units (2023 Grant) (1) 12/10/2025 A(2) 5.1806 (3) (3) Common Stock 5.1806 $0 718.9669 D
Performance-Based Restricted Stock Units (2024 Grant) (1) 12/10/2025 A(2) 1.4761 (4) (4) Common Stock 1.4761 $0 204.8609 D
Restricted Stock Unit (1) 12/10/2025 A(2) 1.7219 02/15/2026 02/15/2026 Common Stock 1.7219 $0 238.9641 D
Restricted Stock Unit (1) 12/10/2025 A(2) 1.3543 02/20/2027 02/20/2027 Common Stock 1.3543 $0 187.9458 D
Restricted Stock Unit (1) 12/10/2025 A(2) 3.7567 02/20/2028 02/20/2028 Common Stock 3.7567 $0 521.3638 D
Explanation of Responses:
1. Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock.
2. Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs.
3. The performance-based RSUs, as adjusted if necessary, vest and convert to shares in one installment after the completion of the third one-year performance period ending December 31, 2025 and the Leadership Development and Compensation Committee's certification of the level of achievement of the applicable performance objectives.
4. The performance-based RSUs, as adjusted if necessary, vest and convert to shares in one installment after the completion of the third one-year performance period ending December 31, 2026 and the Leadership Development and Compensation Committee's certification of the level of achievement of the applicable performance objectives.
Brian Kelly by POA from Fabien Dumont 12/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Autoliv (ALV) report in this Form 4 filing?

The filing reports that Fabien Dumont, Autoliv’s EVP & Chief Technology Officer, received small additional amounts of restricted stock units (RSUs) on December 10, 2025, primarily as dividend-equivalent credits on existing equity awards.

Who is the reporting person in this Autoliv (ALV) Form 4?

The reporting person is Fabien Dumont, who serves as Executive Vice President & Chief Technology Officer of Autoliv Inc.

What type of securities were involved in the Autoliv (ALV) insider transaction?

The transaction involved several types of restricted stock units (RSUs), including performance-based restricted stock units from 2023 and 2024 grants and time-based restricted stock units that relate to Autoliv common stock.

How many additional RSUs did Fabien Dumont receive in this Autoliv (ALV) filing?

The filing lists small RSU accruals such as 5.1806, 1.4761, 1.7219, 1.3543, and 3.7567 RSUs credited to different awards, each representing the right to receive one share of Autoliv common stock upon vesting.

Why did Autoliv (ALV) credit additional RSUs to these awards?

According to the explanation, dividend equivalent rights accrued in the form of additional RSUs. When Autoliv pays cash dividends with a record date on or after the grant date and before vesting, the awards receive additional RSUs that share the same vesting schedule as the original grants.

When do the performance-based RSUs in this Autoliv (ALV) filing vest?

The 2023 performance-based RSUs vest and convert to shares in one installment after the third one-year performance period ending December 31, 2025, following the compensation committee’s certification. The 2024 performance-based RSUs vest similarly after the third performance period ending December 31, 2026.

What is the exercise or purchase price of the RSUs in this Autoliv (ALV) Form 4?

The RSU entries show an exercise price of $0, reflecting that these are restricted stock units rather than stock options; each unit converts into one share of Autoliv common stock if and when vesting conditions are satisfied.

Autoliv Inc

NYSE:ALV

ALV Rankings

ALV Latest News

ALV Latest SEC Filings

ALV Stock Data

9.13B
75.71M
0.32%
72.98%
2.64%
Auto Parts
Motor Vehicle Parts & Accessories
Link
Sweden
OGDEN